Press Releases

Lexicon Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & Medtech Summit	Sep 15, 2021
Lexicon Welcomes New ESC Heart Failure Treatment Guidelines Establishing SGLT Inhibitors as Standard of Care	Aug 30, 2021
Lexicon’s Sotagliflozin Demonstrates Additional Compelling Benefits in Reducing Cardiovascular Endpoints: Results from Soloist and Scored Trials	Aug 23, 2021
Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer	Jul 30, 2021
Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical Update	Jul 30, 2021
Lexicon Pharmaceuticals to Host Second Quarter 2021 Financial Results Conference Call and Webcast on July 30, 2021	Jul 28, 2021
Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Association 81st Scientific Sessions	Jun 25, 2021
Lexicon Pharmaceuticals to Participate in the 2021 Jefferies Virtual Healthcare Conference	May 26, 2021
Lexicon Pharmaceuticals Announces Two Presentations at the American College of Cardiology’s 70th Annual Scientific Session	May 13, 2021
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update	May 06, 2021